期刊
CURRENT MEDICINAL CHEMISTRY
卷 27, 期 39, 页码 6727-6743出版社
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/0929867326666191003154548
关键词
Polycystic ovary syndrome; epigenetic marks; miRNAs; DNA methylation; PCOS phenotypes; PCOS treatment
资金
- National Council Research (CONICET)
- Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) [PICT 632/2016]
- Fundacion Alberto J. Roemmers
Polycystic Ovary Syndrome (PCOS) is a common endocrine and metabolic disorder that affects women in their reproductive age. Recent studies have shown that genes have an important role in the etiology of PCOS. However, the precise way in which these genes are transcriptionally and post-transcriptionally regulated is poorly understood. The aim of the present review is to provide updated information on miRNAs and DNA methylation as epigenetic marks of PCOS. The data presented here allow concluding that both microRNAs and DNA methylation can be considered as possible useful biomarkers when choosing the treatment for a specific PCOS phenotype and thus represent two important tools for the diagnosis and treatment of PCOS patients.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据